Randomization and Blinding Failures Identified in Inspections
Randomization and Blinding Failures Identified in Inspections Why Randomization and Blinding Failures Trigger Regulatory Audit Findings Introduction: The Role of Randomization and Blinding in Clinical Trials Randomization and blinding are critical components of clinical trial design, ensuring unbiased allocation of participants and reducing the risk of investigator or subject bias. Regulatory agencies such as the…
Read More “Randomization and Blinding Failures Identified in Inspections” »